• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Geron Corporation (GERN)

    -NasdaqGS
    3.23 Up 0.15(4.87%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.08
    Open:3.09
    Bid:3.07 x 200
    Ask:3.28 x 100
    1y Target Est:5.50
    Beta:1.48273
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:3.05 - 3.23
    52wk Range:1.76 - 4.67
    Volume:1,850,308
    Avg Vol (3m):2,342,150
    Market Cap:510.80M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNUp 4.87%510.80M
    BMYDown 0.35%101.07B
    GSKUp 0.10%99.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):432.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.12
    Quarterly EPS Est (Sep-15) :0.11
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-5.13

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback